Takeda Pharmaceutical Ltd ADR (TAK)

Chasing high yields alone will ruin an income investor’s returns, so we look at these picks that offer a balance of stability and dividend income growth.

5 of the Best Pharmaceutical Stocks to Buy Right Now

By David Moadel, InvestorPlace Contributor Sep 10, 2020

A handful of pharmaceutical stocks have been on fire lately, but I'm writing for a "buy" prescription for five of the best names now.

Blackstone to Buy Takeda Pharmaceutical Consumer Unit

By William White, InvestorPlace Writer Aug 24, 2020

Blackstone (BX) will be acquiring Takeda Consumer Healthcare, which is the consumer division of Takeda Pharmaceutical (TAK).

7 Pharmaceutical Stocks to Buy for Post-Pandemic Gains

By Louis Navellier and the InvestorPlace Research Staff Jun 9, 2020

Much of the conversation about pharmaceutical stocks rests on the coronavirus, but these high-growth names have potential beyond the pandemic.

Takeda, Biological E. to accelerate access to dengue vaccine in endemic areas (NYSE:TAK)

From Seeking Alpha Feb 27, 2024

Takeda and Indian pharmaceutical company Biological E partner to accelerate access to dengue vaccine, aiming to reach governments in endemic countries by...

Takeda gets FDA approval for eosinophilic esophagitis drug (NYSE:TAK)

From Seeking Alpha Feb 12, 2024

Takeda (TAK) said it has received FDA approval for its drug Eohilia for the treatment of eosinophilic esophagitis in patients 11 years and older. Read more here.

CRISPR CMO who resigned after Casgevy approval lands at Takeda (NASDAQ:CRSP)

From Seeking Alpha Feb 2, 2024

Former CRISPR (CRSP) Chief Medical Officer Phuong Khanh Morrow, who resigned just days after the company won FDA approval for its gene therapy Casgevy, has landed at Takeda (TAK).

Protagonist Therapeutics stock rises on Takeda license deal (NYSE:TAK)

From Seeking Alpha Feb 1, 2024

Protagonist Therapeutics shares surge as it enters a global collaboration with Takeda for the development of its investigational drug, rusfertide.

One Ultra-Cheap High-Yield Dividend Stock to Buy

From The Motley Fool Dec 22, 2023

Now may be a good time for dividend investors to consider loading up on this stock.

2 Ultra-Cheap High-Yield Dividend Stocks to Buy Now

From The Motley Fool Aug 23, 2023

These two high-yield dividend stocks are attractive buys right now.

Takeda Pharmaceutical Ltd ADR (TAK)

3 Stocks to Buy to Benefit From the Booming Sleep Industry

7 Sorry Dividend Stocks to Sell in February Before It’s Too Late

7 Dividend Stocks to Sell Pronto Before a Painful Downturn

7 Stocks Under $15 to Buy and Hold Forever

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Takeda Pharmaceutical Ltd ADR (TAK)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

TAK Stock Predictions, Articles, and Takeda Pharmaceutical Ltd ADR News

Subscriber Sign in